Urol. praxi. 2026;27(1):48-51 | DOI: 10.36290/uro.2025.051
Metastatic prostate cancer mimicking a primary urothelial carcinoma of the bladder
- Oddelenie urológie, Fakultná nemocnica J. A. Reimana, Prešov
A 67-year-old patient with several months of recurrent urinary retention with subsequent occurrence of gross hematuria, while palpation of the prostate and the level of total prostate-specific antigen were not significant for prostate cancer. Cystoscopy revealed papillomatous formations in the prostatic urethra, subsequently also in the neck, trigone and posterior wall of the bladder, and urine cytology was suspicious for high-grade urothelial carcinoma. The patient underwent transurethral resection of pathological lesions with the finding of prostatic adenocarcinoma with Gleason score 10. As part of the differential diagnosis, in patients with lesions in the neck, base, or posterior wall of the bladder, it is necessary to consider the diagnosis of prostate cancer, as it may mimic primary urothelial carcinoma.
Keywords: prostate cancer, urothelial carcinoma, cystoscopy, transurethral resection, metastases.
Received: June 12, 2025; Revised: June 12, 2025; Accepted: July 8, 2025; Prepublished online: July 8, 2025; Published: March 16, 2026 Show citation
References
- Adnan A, Basu S. Comparison of Dual-Tracer PET and CT Features to Conventional Risk Categories in Assessing Response to 177Lu-PSMA-617 Therapy for Metastatic Prostate Adenocarcinoma with Urinary Bladder Involvement. J Nucl Med Technol. [Internet]. 2020;48(2):148-153. [cited 2025 May 12]. Available from: https://tech.snmjournals.org/content/48/2/148.long.
Go to original source... - Spazzapan M, Ahmed MS, Tasleem A, Nkwam N. Prostate cancer metastasis mimicking a primary urothelial carcinoma of the bladder. J Surg Case Rep. [Internet]. 2022;2022(6): rjac275. [cited 2025 May 12]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9197304/. Go to original source...
- Liu R, Xie X, Zhang Z, Xu Y. A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder. Eur J Med Res. [Internet]. 2013;18(1):36. [cited 2025 May 12]. Available from: https://pubmed.ncbi.nlm.nih.gov/24090000/. Go to original source...
- Autorino R, Di Lorenzo G, Giannarini G, et al. Looking at the prostates of patients with bladder cancer: a thoughtful exercise. BJU Int. [Internet]. 2009;104(2):160-162. [cited 2025 May 13]. Available from: https://pubmed.ncbi.nlm.nih.gov/19338547/. Go to original source...
- Schafer EJ, Laversanne M, Sung H, et al. Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update. Eur Urol. [Internet]. 2025;87(3):302-313. [cited 2025 May 12]. Available from: https://pubmed.ncbi.nlm.nih.gov/39668103/. Go to original source...
- Okubo K, Hamabe F, Miyai K, et al. Prostate cancer recurrence mimicking invasive urothelial cancer of the bladder. Urol Case Rep. [Internet]. 2020;33:101421. [cited 2025 May 13]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7574274/#sec3. Go to original source...
- Ondruš D, Cuninková M, Pleško I. Nádory močového mechúra. Urolog. pro Praxi. [Internet]. 2004;6:243-245. [cited 2025 May 13] Available from: https://www.urologiepropraxi.cz/artkey/uro-200406-0002_Nadory_mocoveho_mechura.php?l=en.
- Gordetsky J, Epstein JI. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Am J Surg Pathol. [Internet]. 2014;38(7):941-945. [cited 2025 May 13]. Available from: https://pubmed.ncbi.nlm.nih.gov/24503758/. Go to original source...
- Schloegel V, Alam SM, Dennis K, et al. Near-Miss Diagnoses of Solitary Bladder Tumors Highlight the Importance of Immunohistochemical Staining. Case Rep Urol. [Internet]. 2020;2020: 8855451. [cited 2025 May 13]. Available from: https://pubmed.ncbi.nlm.nih.gov/33381348/. Go to original source...
- Chuang AY, DeMarzo AM, Veltri RW, et al. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol. [Internet]. 2007;31(8):1246-1255. [cit. 13-05-2025]. doi: 10.1097/PAS.0b013e31802f5d33. Available from: https://pubmed.ncbi.nlm.nih.gov/17667550/. Go to original source...
Go to PubMed... - Král M, Kudláčková Š. Karcinom prostaty - co bychom měli znát o diagnostice. Med. praxi. [Internet]. 2019;16(1):48-52. [cited 2025 May 14]. Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.solen.cz/pdfs/med/2019/01/10.pdf. Go to original source...
- Katolícka J. Hormonálni léčba karcinomu prostaty. Onkologie [Internet]. 2014;8(5):228-230. [cited 2025 May 14]. Dostupné z: chrome extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.onkologiecs.cz/pdfs/xon/2 14/05/09.pdf.
- Kryštofová D. Combination therapy in advanced primary metastatic hormone-sensitive prostate cancer. Onkologie [Internet]. 2024;18(3):213-215. [cited 2025 May 14]. Available from: https://www.onkologiecs.cz/artkey/xon-2024030011_kombinovana_terapie_u_pokrocileho_primarne_metastatickeho_hormonalne_senzitivniho_karcinomu_prostaty.php?l=en. Go to original source...